Aggressive investor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thx for posting $LPCN chart. As per chart, new 52 weeks high by tomorrow
$LPCN ok I'm calling 20 by sept 14. I'm feeling real bullish with this now. Couple upgrades and lift off imo!
$LPCN ok I'm calling 20 by sept 14. I'm feeling real bullish with this now. Couple upgrades and lift off imo!
$LPCN Lipocine Inc. Analyst Rating Update
http://www.americantradejournal.com/lipocine-inc-analyst-rating-update/663398/
From Yahoo board....
http://finance.yahoo.com/mbview/threadview/?&/mbview/threadview/?&bn=a01e6608-f2fb-371e-a4e7-481bf9668858&tid=1437412577513-d505b347-9ba9-424e-a7ee-281fe4b653f5
$LPCN Lipocine Inc. Analyst Rating Update
http://www.americantradejournal.com/lipocine-inc-analyst-rating-update/663398/
From Yahoo board....
http://finance.yahoo.com/mbview/threadview/?&/mbview/threadview/?&bn=a01e6608-f2fb-371e-a4e7-481bf9668858&tid=1437412577513-d505b347-9ba9-424e-a7ee-281fe4b653f5
$LPCN Large Outflow of Money Witnessed in Lipocine Inc.
Currently the company Insiders own 48.77% of Lipocine Inc. Company shares. In the past six months, there is a change of 0% in the total insider ownership. Institutional Investors own 47.9% of Company shares.
http://www.moneyflowindex.org/large-outflow-of-money-witnessed-in-lipocine-inc/3119621/
$LPCN Large Outflow of Money Witnessed in Lipocine Inc.
Currently the company Insiders own 48.77% of Lipocine Inc. Company shares. In the past six months, there is a change of 0% in the total insider ownership. Institutional Investors own 47.9% of Company shares.
http://www.moneyflowindex.org/large-outflow-of-money-witnessed-in-lipocine-inc/3119621/
$LPCN targeting 2.0 billion market submitted NDA to FDA today
http://globenewswire.com/news-release/2015/08/31/764746/10147555/en/Lipocine-Submits-New-Drug-Application-to-FDA-for-Its-Oral-Testosterone-Replacement-Product-Candidate-LPCN-1021.html
Investors presentation
http://files.shareholder.com/downloads/AMDA-2BVSIV/490939947x0x844950/E65ECD81-CBBF-4A1E-8ECD-714DA1016A83/LPCN_Presentation_August_2015..pdf
thx. looking good
$LPCN Its going to stay above 16.00 this time. 20 should be only few weeks away. Maybe days
http://globenewswire.com/news-release/2015/08/31/764746/10147555/en/Lipocine-Submits-New-Drug-Application-to-FDA-for-Its-Oral-Testosterone-Replacement-Product-Candidate-LPCN-1021.html
$LPCN Its going to stay above 16.00 this time. 20 should be only few weeks away. Maybe days
http://globenewswire.com/news-release/2015/08/31/764746/10147555/en/Lipocine-Submits-New-Drug-Application-to-FDA-for-Its-Oral-Testosterone-Replacement-Product-Candidate-LPCN-1021.html
$LPCN Submits New Drug Application to FDA for Its Oral Testosterone
http://globenewswire.com/news-release/2015/08/31/764746/10147555/en/Lipocine-Submits-New-Drug-Application-to-FDA-for-Its-Oral-Testosterone-Replacement-Product-Candidate-LPCN-1021.html#sthash.MngQEHDY.dpuf
$LPCN Submits New Drug Application to FDA for Its Oral Testosterone
http://globenewswire.com/news-release/2015/08/31/764746/10147555/en/Lipocine-Submits-New-Drug-Application-to-FDA-for-Its-Oral-Testosterone-Replacement-Product-Candidate-LPCN-1021.html#sthash.MngQEHDY.dpuf
The near collapse of China’s stock market in recent weeks scared the hell out of the entire world but, at least so far, really has not mattered very much. China’s markets are insulated from the rest of the world. They serve as a way of letting average people share some of China’s growth and as a form of national lottery – call it Beijing bingo.
Western stock markets are also semi-rigged casino games in which the big boys and their ultra high speed computer systems almost always win at the expense of small fry........
http://ericmargolis.com/2015/08/beijing-bingo/
The near collapse of China’s stock market in recent weeks scared the hell out of the entire world but, at least so far, really has not mattered very much. China’s markets are insulated from the rest of the world. They serve as a way of letting average people share some of China’s growth and as a form of national lottery – call it Beijing bingo.
Western stock markets are also semi-rigged casino games in which the big boys and their ultra high speed computer systems almost always win at the expense of small fry........
http://ericmargolis.com/2015/08/beijing-bingo/
$LPCN Looking like a pretty obvious bullish flag on the daily chart. Wouldn't surprise me to see continued durable gains next week
$LPCN looking good. GL
might break 52 weeks high anytime. Institutional investors slowly and silently increasing their position in LPCN
http://whalewisdom.com/stock/mbar
Institutional investors slowly and silently increasing their position in $LPCN
http://www.conferencecalltranscripts.org/summaryh/?id=1925973
Early bird now, price target $36.00
http://www.americantradejournal.com/roth-capital-rating-update-on-lipocine-inc-nasdaqlpcn/642661/
$LPCN looking good $20 by EOM
I guess
Roth Capital Rating Update on Lipocine Inc. (NASDAQ:LPCN)
http://www.americantradejournal.com/roth-capital-rating-update-on-lipocine-inc-nasdaqlpcn/642661/
Roth Capital Rating Update on Lipocine Inc. (NASDAQ:LPCN)
http://www.americantradejournal.com/roth-capital-rating-update-on-lipocine-inc-nasdaqlpcn/642661/
$LPCN - here is the yesterday's presentation: Opening the door to a $1B market potential
http://www.getfilings.com/sec-filings/150812/Lipocine-Inc_8-K/v417603_ex99-1.htm
First in kind "ORAL TESTOSTERONE"
$LPCN - here is the yesterday's presentation: Opening the door to a $1B market potential
http://www.getfilings.com/sec-filings/150812/Lipocine-Inc_8-K/v417603_ex99-1.htm
First in kind "ORAL TESTOSTERONE"
$LPCN Current price $16.00 Target $36.00 Short Term: $25.00
$LPCN to Present at 35th Annual Canaccord Genuity Growth Conference at 1PM EST TODAY
http://globenewswire.com/news-release/2015/08/05/758084/10144632/en/Lipocine-to-Present-at-35th-Annual-Canaccord-Genuity-Growth-Conference.html
$LPCN: Well-Positioned to File LPCN 1021 NDA with Enough Cash to Accelerate Programs for Lead Assets… Filing to FDA anytime-
http://finance.yahoo.com/news/lpcn-well-positioned-file-lpcn-144500840.html
Outstanding Shares: 18.20 million
Institution Hold 37 % (Baker bros has position in it....lol)
Price Target/Analyst Rating links
Roth Capital Rating $36.00: http://www.americantradejournal.com/roth-capital-rating-update-on-lipocine-inc-nasdaqlpcn/642661/
ZACKS SHORT TERM RATING $22.75: http://www.otcoutlook.com/zacks-short-term-rating-on-lipocine-inc-nasdaqlpcn/661096/
Benzing a short term rating $25.00: http://www.benzinga.com/stock/lpcn/ratings
More rating: http://www.theflyonthewall.com/permalinks/entry.php/https?symbol=LPCN&page=all
**Super Phase 3 met all endpoints: Blockbuster product http://files.shareholder.com/downloads/AMDA-2BVSIV/547432318x0x837240/524a9903-54f4-480e-9bb8-2ae3b1f07a5f/LPCN_News_2015_6_29_General_Releases.pdf
$LPCN Buy the dip. Major catalyst with an upcoming NDA in August/Sept 2015. A potential partnership or buyout.
Good Luck!!!
****To MODS of the board: Each and every word backed up by links. Please do not consider this post SPAM.
$LPCN Current price $16.00 Target $36.00 Short Term: $25.00
$LPCN to Present at 35th Annual Canaccord Genuity Growth Conference at 1PM EST TODAY
http://globenewswire.com/news-release/2015/08/05/758084/10144632/en/Lipocine-to-Present-at-35th-Annual-Canaccord-Genuity-Growth-Conference.html
$LPCN: Well-Positioned to File LPCN 1021 NDA with Enough Cash to Accelerate Programs for Lead Assets… Filing to FDA anytime-
http://finance.yahoo.com/news/lpcn-well-positioned-file-lpcn-144500840.html
Outstanding Shares: 18.20 million
Institution Hold 37 % (Baker bros has position in it....lol)
Price Target/Analyst Rating links
Roth Capital Rating $36.00: http://www.americantradejournal.com/roth-capital-rating-update-on-lipocine-inc-nasdaqlpcn/642661/
ZACKS SHORT TERM RATING $22.75: http://www.otcoutlook.com/zacks-short-term-rating-on-lipocine-inc-nasdaqlpcn/661096/
Benzing a short term rating $25.00: http://www.benzinga.com/stock/lpcn/ratings
More rating: http://www.theflyonthewall.com/permalinks/entry.php/https?symbol=LPCN&page=all
**Super Phase 3 met all endpoints: Blockbuster product http://files.shareholder.com/downloads/AMDA-2BVSIV/547432318x0x837240/524a9903-54f4-480e-9bb8-2ae3b1f07a5f/LPCN_News_2015_6_29_General_Releases.pdf
$LPCN Buy the dip. Major catalyst with an upcoming NDA in August/Sept 2015. A potential partnership or buyout.
Good Luck!!!
$DVAX let's break $30! then easy next leg $36
Keep an eye on $DVAX....
$DVAX in billion dollar market cap club!!!! wow
Welcome. She deserves more
First target $36 approaching
$DVAX Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock http://www.smarteranalyst.com/2015/07/28/company-update-nasdaqdvax-dynavax-technologies-corporation-announces-exercise-in-full-of-over-allotment-option-and-completion-of-public-offering-of-common-stock/
$DVAX total Cash in hand now will be $250 million
http://www.smarteranalyst.com/2015/07/22/company-update-nasdaqdvax-dynavax-technologies-corporation-prices-public-offering-of-common-stock/
next is?
Receptos was bought out without completing phase III trials for $7.2 Billion
http://www.cnbc.com/2015/07/14/celgene-to-acquire-receptos-for-more-than-7b.html
Short Interest Update of $DVAX
-The bets have increased to 5,892,986 shares on June 30,2015 from 5,849,539 shares on June 15,2015.
- days to cover 12
- Average volume to cover daily 478,019
Source FINRA: http://www.insidertradingreport.org/short-interest-update-of-dynavax-technologies-corporation-nasdaqdvax/637116/
Have fun
$DVAX's outperform rating reiterated at William Blair. $42.00 PT.
http://www.marketbeat.com/stocks/NASDAQ/DVAX/?RegistrationCode=SocialMedia-StockTwits
Do you know this?
$DVAX institutional holding only: 91.36%
http://www.nasdaq.com/symbol/dvax/institutional-holdings
Phase 3 result by October 2015
Zero Debt
Cash in hand close to 100 million
$DVAX: in Spotlight
http://www.streetreport.co/dynavax-technologies-corp-nasdaqdvax-in-spotlight/17742/
Phase III result by October 2015
$DVAX: There is major upside or this stock would be trading much lower market cap. After all, who would still stay the course with Dynavax for just a 20% to 30% potential gain with a risk of losing 70% or more on FDA rejection. The answer is simple! Dynavax would be worth 3x multiple of peak sales (growing) and likely 5x on buyout without SD-101. On Heplisav alone, it would value conservatively a buyout at $1.8 Billion meaning we have much more upside and the risk on the second go around is worth the high return.
I suspect that many are starting to believe the SD-101 potential and thus are willing to continue to drive market cap higher.
There are plenty of clinical Cancer biotech companies with no approved drug that are trading well north of $2 Billion. If Dynavax shows any positive results from Standford or Merk trials, we will easily surpass $2 billion market cap especial with buyout interest from plenty of big pharma that need to fill up there pipeline on expiring patents. I'm staying in through mid next year on likely FDA approval and the SD-101 trial results likely to come out by Q3'2016. At that time, I will determine whether to stay invested or bail out and move into my next investments.
$DVAX News today is actually the bigger catalyst and turning point
$DVAX now only bio play with no risk
Company Update (NASDAQ:DVAX): Dynavax Technologies Corporation Announces Third Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) and Updates Financial Status
http://www.smarteranalyst.com/2015/07/09/company-update-nasdaqdvax-dynavax-technologies-corporation-announces-third-independent-dsmb-recommendation-to-continue-phase-3-study-of-heplisav-btm-and-updates-financial-status/